A reduction in biomarkers of systemic inflammation, such as ferritin, C-reactive protein, and the inflammatory index Neutrophil/Lymphocyte ratio (NLR), was observed, especially in the LC subgroup of cancer patients treated with Lip. The gene discussed is CRP; the disease is cancer.